Clinical Impact of Lymphadenectomy after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Review of Available Data

Recent robust data allow for omitting lymph node dissection for patients with advanced epithelial ovarian cancer (EOC) and without any suspicion of lymph node metastases, without compromising recurrence-free survival (RFS), nor overall survival (OS), in the setting of primary surgical treatment. Evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidler, Stephanie, Koual, Meriem, Achen, Guillaume, Bentivegna, Enrica, Fournier, Laure, Delanoy, Nicolas, Nguyen-Xuan, Huyên-Thu, Bats, Anne-Sophie, Azaïs, Henri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830759/
https://www.ncbi.nlm.nih.gov/pubmed/33477449
http://dx.doi.org/10.3390/jcm10020334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830759/
https://www.ncbi.nlm.nih.gov/pubmed/33477449
http://dx.doi.org/10.3390/jcm10020334

Ejemplares similares